Publication: Outpatient Treatment of Osteomyelitis with Telavancin

Published July 2017

Claudia P. Schroeder, PharmD, PhD
Lucinda J. Van Anglen, PharmD
Robin H. Dretler, MD
John S. Adams, MD, FIDSA, FSHEA
Richard C. Prokesch, MD, FACP, FIDSA
Quyen Luu, MD
Andrew H. Krinsky, MD

View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.